The present application describes novel cyclic hydroxamic acids of formula I:
1
or pharmaceutically acceptable salt forms thereof, wherein ring B is a 5-7 membered cyclic system containing from 0-2 heteroatoms selected from O, N, NR
a
, and S(O)
p
, and 0-1 carbonyl groups and the other variables are defined in the present specification, which are useful as metalloprotease inhibitors.
本申请描述了新型的环状羟
肟酸,其
化学式为I:1或其药用盐形式,其中环B为包含0-2个来自O、N、NRa和S(O)p的杂原子和0-1个羰基基团的5-7元环系统,而其他变量在本说明书中有定义,这些化合物可用作
金属蛋白酶抑制剂。